Azathioprine treatment during lactation

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 1, 2009, Pages 90-91

  Zelinkova, Z ^a   De Boer, I P ^b   Van Dijke, M J ^c   Kuipers, E J ^a   Van Der Woude, C J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c General Practitioner   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLTHIOINOSINE; AZATHIOPRINE; TIOGUANINE;

ADULT; BREAST FEEDING; CASE REPORT; CHILD; CROHN DISEASE; DRUG BLOOD LEVEL; DRUG MONITORING; ERYTHROCYTE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LETTER; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; BREAST FEEDING; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LACTATION; MILK, HUMAN; PREGNANCY;

EID: 67449093036     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.03996.x     Document Type: Letter

References (4)

1. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008 28 : 1209 13.
2. Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel diseas. Clin Pharmacokinetic 2001 40 : 723 51.
3. Lennard L. TPMT in the treatment of Crohn's disease with azathioprine. Gut 2002 51 : 143 6.
4. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast mil is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006 62 : 453 6.